Search Results for
“instagram加指定用户粉丝👉【SMMFS.COM】中文粉丝,ncR”
September 20, 2021
IMPACT REPORT 2020 – 2021 __________ PATIENT STORYJOYCE CRAWFORD Joyce’s father had osteoporosis and even though her grandmother wasn’t formally diagnosed, she had signs of the disease including her […]
![](/wp-content/themes/yootheme/cache/74/1-3-ocblog-Your-bone-health-during-covid-19-7429e0f0.jpeg)
April 2, 2020
Take action to make sure you are staying fracture-free and are taking care of your bone health. This pandemic has put enormous pressure on our healthcare systems stretching our resources […]
November 19, 2020
PRESS RELEASE TORONTO, November 19, 2020 – Dr. Earl Bogoch has been appointed the inaugural holder of the Brookfield Chair in Fracture Prevention. Dr. Famida Jiwa, President & CEO, Osteoporosis […]
![](/wp-content/themes/yootheme/cache/8e/iStock-1381044412-600x375-1-8e68a4e0.jpeg)
February 24, 2023
Osteoporosis can have a significant impact on our physical and emotional well-being including how broken bones and the diagnosis of osteoporosis can affect our sexuality and intimacy. Sexuality can be […]
November 4, 2021
MEET THE CMC FACULTY Dr. Cathy Craven University of Toronto Toronto, ON Cathy Craven is the Toronto Rehabilitation Institute/ University of Toronto Chair in Spinal Cord Injury (SCI) Rehabilitation, Professor […]
![](/wp-content/themes/yootheme/cache/62/1-3-ocblog-osteoporosis-drug-treatments-covid-19-62bf8ea3.jpeg)
April 17, 2020
As we work to adjust to our new normal during COVID-19, now more than ever, staying fracture-free is critical for anyone with osteoporosis. Healthcare systems are over-stretched, with general recommendations […]
April 8, 2019
Get Involved What you can do We were the world’s first-ever osteoporosis-dedicated organization, the first to establish guidelines for long-term treatment and exercise, and the first to introduce fracture risk […]
November 27, 2008
We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]
July 14, 2009
We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]